세계의 지속적신대체요법(CRRT) 시장 : 모달리티, 제품, 지역별, 경쟁 구도 - 분석과 예측(2024-2033년)

“Global Continuous Renal Replacement Therapy Market Poised for Remarkable Growth.”

The global continuous renal replacement therapy (CRRT) market is witnessing significant growth, driven by the increasing prevalence of acute kidney injuries (AKI) and the rising demand for advanced renal care solutions. CRRT serves as a vital intervention for patients with impaired kidney function, offering a continuous and efficient method for blood purification. The market is characterized by the adoption of innovative modes, such as hemofiltration, hemodiafiltration, hemodialysis, etc. enhancing the efficiency and efficacy of CRRT procedures.

Factors contributing to the market's expansion include a growing geriatric population, a rise in the incidence of sepsis and multiple organ failure, and advancements in healthcare infrastructure. Additionally, the increasing awareness among healthcare professionals about the benefits of CRRT in managing critically ill patients is bolstering market growth.

Market Segmentation:

Segmentation 1: by Modality

• Continuous Venovenous Hemofiltration (CVVH)
• Continuous Venovenous Hemodiafiltration (CVVHDF)
• Continuous Venovenous Hemodialysis (CVVHD)
• Slow Continuous Ultrafiltration (SCUF)

Segmentation 2: by Product

• Continuous Renal Replacement System
• Disposables
• Dialysates and Replacement Fluids

Segmentation 3: by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World

Key Questions Answered in this Report:

• What are the focus segments of the global continuous renal replacement therapy market in the upcoming years?
• What is the value of revenue generated from the continuous renal replacement therapy market across the globe and at what rate is the demand expected to grow in the forecast period?
• Which product will be the most revenue-generating in the global continuous renal replacement therapy market?
• Which continuous renal replacement therapy segment is estimated to hold the largest share of the market globally?
• Which product segment is expected to grow at the highest CAGR during the forecast period?
• Which modality segment accounted for the largest share of the continuous renal replacement therapy market?
• What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global continuous renal replacement therapy market? What are the major challenges faced by the existing players in the market?
• Who are the major players dominating the global continuous renal replacement therapy market space?
• Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the continuous renal replacement therapy market for the forecast period?
• What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global continuous renal replacement therapy market? What are the major challenges faced by the existing players in the market?
• Who are the major players dominating the global continuous renal replacement therapy market space?
• Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the continuous renal replacement therapy market for the forecast period?

Table of Contents

Executive Summary

1. Markets

• 1.1. Trends : Current and Future Impact Assessment
  • 1.1.1. Sample Text
  • 1.1.2. Trend 1
  • 1.1.3. Trend 2
  • 1.1.4. Trend 3
• 1.2. Supply chain Overview
  • 1.2.1. Value Chain Analysis
  • 1.2.2. Market Map
• 1.3. Research and Development Review
  • 1.3.1. Patent Filing Trend (by Country, Company)
• 1.4. Regulatory Landscape
• 1.5. Impact Analysis for Key Global Events- COVID- 19
• 1.6. Market Dynamics Overview
  • 1.6.1. Market Drivers
  • 1.6.2. Market Restraints
  • 1.6.3. Market Opportunities

2. Application

• 2.1. Application Segmentation
• 2.2. Application Summary
• 2.3. Global Continuous Renal Replacement Therapy Market (by Modality)
  • 2.3.1. Continuous Venovenous Hemofiltration (CVVH)
  • 2.3.2. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 2.3.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 2.3.4. Slow Continuous Ultrafiltration (SCUF)

3. Products

• 3.1. Product Segmentation
• 3.2. Product Summary
• 3.3. Global Continuous Renal Replacement Therapy Market - (by Type)
  • 3.3.1. Market Overview
    • 3.3.1.1. Analyst View
• 3.4. Global Continuous Renal Replacement Therapy Market (by Product)
  • 3.4.1. Continuous Renal Replacement System
  • 3.4.2. Disposables
    • 3.4.2.1. Hemofilters
    • 3.4.2.2. Bloodline Sets & Tubes
    • 3.4.2.3. Others
  • 3.4.3. Dialysates and Replacement Fluids

4. Regions

• 4.1. Regional Summary
• 4.2. Drivers and Restraints
• 4.3. North America
  • 4.3.1. Regional Overview
  • 4.3.2. Driving Factors for Market Growth
  • 4.3.3. Factors Challenging the Market
  • 4.3.4. Application
  • 4.3.5. Product
  • 4.3.6. U.S.
  • 4.3.7. U.S. Continuous Renal Replacement Therapy Market by Modality
  • 4.3.8. U.S. Continuous Renal Replacement Therapy Market by Product
  • 4.3.9. Canada
  • 4.3.10. Canada Continuous Renal Replacement Therapy Market by Modality
  • 4.3.11. Canada Continuous Renal Replacement Therapy Market by Product
• 4.4. Europe
  • 4.4.1. Regional Overview
  • 4.4.2. Driving Factors for Market Growth
  • 4.4.3. Factors Challenging the Market
  • 4.4.4. Application
  • 4.4.5. Product
  • 4.4.6. Germany
  • 4.4.7. Germany Continuous Renal Replacement Therapy Market by Modality
  • 4.4.8. Germany Continuous Renal Replacement Therapy Market by Product
  • 4.4.9. U.K.
  • 4.4.10. U.K. Continuous Renal Replacement Therapy Market by Modality
  • 4.4.11. U.K. Continuous Renal Replacement Therapy Market by Product
  • 4.4.12. France
  • 4.4.13. France Continuous Renal Replacement Therapy Market by Modality
  • 4.4.14. France Continuous Renal Replacement Therapy Market by Product
  • 4.4.15. Italy
  • 4.4.16. Italy Continuous Renal Replacement Therapy Market by Modality
  • 4.4.17. Italy Continuous Renal Replacement Therapy Market by Product
  • 4.4.18. Spain
  • 4.4.19. Spain Continuous Renal Replacement Therapy Market by Modality
  • 4.4.20. Spain Continuous Renal Replacement Therapy Market by Product
  • 4.4.21. Netherlands
  • 4.4.22. Netherlands Continuous Renal Replacement Therapy Market by Modality
  • 4.4.23. Netherlands Continuous Renal Replacement Therapy Market by Product
  • 4.4.24. Rest of Europe
  • 4.4.25. Rest of Europe Continuous Renal Replacement Therapy Market by Modality
  • 4.4.26. Rest of Europe Continuous Renal Replacement Therapy Market by Product
• 4.5. Asia Pacific
  • 4.5.1. Regional Overview
  • 4.5.2. Driving Factors for Market Growth
  • 4.5.3. Factors Challenging the Market
  • 4.5.4. Application
  • 4.5.5. Product
  • 4.5.6. China
  • 4.5.7. China Continuous Renal Replacement Therapy Market by Modality
  • 4.5.8. China Continuous Renal Replacement Therapy Market by Product
  • 4.5.9. Japan
  • 4.5.10. Japan Continuous Renal Replacement Therapy Market by Modality
  • 4.5.11. Japan Continuous Renal Replacement Therapy Market by Product
  • 4.5.12. South Korea
  • 4.5.13. South Korea Continuous Renal Replacement Therapy Market by Modality
  • 4.5.14. South Korea Continuous Renal Replacement Therapy Market by Product
  • 4.5.15. Australia
  • 4.5.16. Australia Continuous Renal Replacement Therapy Market by Modality
  • 4.5.17. Australia Continuous Renal Replacement Therapy Market by Product
  • 4.5.18. India
  • 4.5.19. India Continuous Renal Replacement Therapy Market by Modality
  • 4.5.20. India Continuous Renal Replacement Therapy Market by Product
  • 4.5.21. Rest-of-Asia-Pacific
  • 4.5.22. Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market by Modality
  • 4.5.23. Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market by Product
• 4.6. Latin America
  • 4.6.1. Regional Overview
  • 4.6.2. Driving Factors for Market Growth
  • 4.6.3. Factors Challenging the Market
  • 4.6.4. Application
  • 4.6.5. Product
  • 4.6.6. Brazil
  • 4.6.7. Brazil Continuous Renal Replacement Therapy Market by Modality
  • 4.6.8. Brazil Continuous Renal Replacement Therapy Market by Product
  • 4.6.9. Mexico
  • 4.6.10. Mexico Continuous Renal Replacement Therapy Market by Modality
  • 4.6.11. Mexico Continuous Renal Replacement Therapy Market by Product
  • 4.6.12. Rest-of-Latin America
  • 4.6.13. Rest-of-Latin-America Continuous Renal Replacement Therapy Market by Modality
  • 4.6.14. Rest-of-Latin-America Continuous Renal Replacement Therapy Market by Product
• 4.7. Rest-of-the-World (RoW)
  • 4.7.1. Regional Overview
  • 4.7.2. Driving Factors for Market Growth
  • 4.7.3. Factors Challenging the Market
  • 4.7.4. Application
  • 4.7.5. Product

5. Markets - Competitive Benchmarking & Company Profiles

• 5.1. Next Frontiers…..
• 5.2. Geographic Assessment
  • 5.2.1. B. Braun SE
    • 5.2.1.1. Overview
    • 5.2.1.2. Top Products / Product Portfolio
    • 5.2.1.3. Top Competitors
    • 5.2.1.4. Target Customers
    • 5.2.1.5. Key Personnel
    • 5.2.1.6. Analyst View
    • 5.2.1.7. Market Share
  • 5.2.2. Baxter
    • 5.2.2.1. Overview
    • 5.2.2.2. Top Products / Product Portfolio
    • 5.2.2.3. Top Competitors
    • 5.2.2.4. Target Customers
    • 5.2.2.5. Key Personnel
    • 5.2.2.6. Analyst View
    • 5.2.2.7. Market Share
  • 5.2.3. Fresenius Medical Care AG
    • 5.2.3.1. Overview
    • 5.2.3.2. Top Products / Product Portfolio
    • 5.2.3.3. Top Competitors
    • 5.2.3.4. Target Customers
    • 5.2.3.5. Key Personnel
    • 5.2.3.6. Analyst View
    • 5.2.3.7. Market Share
  • 5.2.4. Asahi Kasei Corporation
    • 5.2.4.1. Overview
    • 5.2.4.2. Top Products / Product Portfolio
    • 5.2.4.3. Top Competitors
    • 5.2.4.4. Target Customers
    • 5.2.4.5. Key Personnel
    • 5.2.4.6. Analyst View
    • 5.2.4.7. Market Share
  • 5.2.5. NIPRO CORPORATION
    • 5.2.5.1. Overview
    • 5.2.5.2. Top Products / Product Portfolio
    • 5.2.5.3. Top Competitors
    • 5.2.5.4. Target Customers
    • 5.2.5.5. Key Personnel
    • 5.2.5.6. Analyst View
    • 5.2.5.7. Market Share
  • 5.2.6. Toray Medical Co. Ltd.
    • 5.2.6.1. Overview
    • 5.2.6.2. Top Products / Product Portfolio
    • 5.2.6.3. Top Competitors
    • 5.2.6.4. Target Customers
    • 5.2.6.5. Key Personnel
    • 5.2.6.6. Analyst View
    • 5.2.6.7. Market Share
  • 5.2.7. Medtronic plc
    • 5.2.7.1. Overview
    • 5.2.7.2. Top Products / Product Portfolio
    • 5.2.7.3. Top Competitors
    • 5.2.7.4. Target Customers
    • 5.2.7.5. Key Personnel
    • 5.2.7.6. Analyst View
    • 5.2.7.7. Market Share
  • 5.2.8. Medica S.p.A
    • 5.2.8.1. Overview
    • 5.2.8.2. Top Products / Product Portfolio
    • 5.2.8.3. Top Competitors
    • 5.2.8.4. Target Customers
    • 5.2.8.5. Key Personnel
    • 5.2.8.6. Analyst View
    • 5.2.8.7. Market Share
  • 5.2.9. Anjue Medical Equipment Co., Ltd.
    • 5.2.9.1. Overview
    • 5.2.9.2. Top Products / Product Portfolio
    • 5.2.9.3. Top Competitors
    • 5.2.9.4. Target Customers
    • 5.2.9.5. Key Personnel
    • 5.2.9.6. Analyst View
    • 5.2.9.7. Market Share
  • 5.2.10. Ningbo Tinyani Medical Equipment
    • 5.2.10.1. Overview
    • 5.2.10.2. Top Products / Product Portfolio
    • 5.2.10.3. Top Competitors
    • 5.2.10.4. Target Customers
    • 5.2.10.5. Key Personnel
    • 5.2.10.6. Analyst View
    • 5.2.10.7. Market Share
  • 5.2.11. Nikkiso Co., Ltd.
    • 5.2.11.1. Overview
    • 5.2.11.2. Top Products / Product Portfolio
    • 5.2.11.3. Top Competitors
    • 5.2.11.4. Target Customers
    • 5.2.11.5. Key Personnel
    • 5.2.11.6. Analyst View
    • 5.2.11.7. Market Share
  • 5.2.12. SWS Hemodialysis Co., ltd
    • 5.2.12.1. Overview
    • 5.2.12.2. Top Products / Product Portfolio
    • 5.2.12.3. Top Competitors
    • 5.2.12.4. Target Customers
    • 5.2.12.5. Key Personnel
    • 5.2.12.6. Analyst View
    • 5.2.12.7. Market Share
  • 5.2.13. Informed SA
    • 5.2.13.1. Overview
    • 5.2.13.2. Top Products / Product Portfolio
    • 5.2.13.3. Top Competitors
    • 5.2.13.4. Target Customers
    • 5.2.13.5. Key Personnel
    • 5.2.13.6. Analyst View
    • 5.2.13.7. Market Share
  • 5.2.14. Medical Components, Inc.
    • 5.2.14.1. Overview
    • 5.2.14.2. Top Products / Product Portfolio
    • 5.2.14.3. Top Competitors
    • 5.2.14.4. Target Customers
    • 5.2.14.5. Key Personnel
    • 5.2.14.6. Analyst View
    • 5.2.14.7. Market Share
  • 5.2.15. CytoSorbents Corporation
    • 5.2.15.1. Overview
    • 5.2.15.2. Top Products / Product Portfolio
    • 5.2.15.3. Top Competitors
    • 5.2.15.4. Target Customers
    • 5.2.15.5. Key Personnel
    • 5.2.15.6. Analyst View
    • 5.2.15.7. Market Share

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
  • 6.1.3. Data Triangulation
• 6.2. Market Estimation and Forecast